A case of cellulitis complicating Campylobacter jejuni subspecies jejuni bacteremia and review of the literature.
Infection with Campylobacter species is a predominant cause of food-borne gastroenteritis in the industrialized world. Bacteremia is detected in <1% of patients with diarrhea, mainly in immunocompromised hosts or those in the extremes of age. Reported here is the case of a 78-year-old, immunocompromised male patient with Campylobacter jejuni subsp. jejuni bacteremia complicated by cellulitis. The infection was characterized by a protracted course with several recurrences and refractoriness to multiple antibiotic regimens, responding only to a prolonged course of meropenem treatment. The frequency of cellulitis as reflected in previously reported series of Campylobacter bacteremia and the clinical characteristics of this difficult-to-treat infection are reviewed.
Monselise
A
A
Department of Internal Medicine B, Rabin Medical Center, Beilinson Campus, Petach-Tikva, Israel.
Blickstein
D
D
Ostfeld
I
I
Segal
R
R
Weinberger
M
M
D000368:Aged; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D002169:Campylobacter Infections / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016123:Campylobacter jejuni / Q000302:isolation & purification*; D002481:Cellulitis / Q000188:drug therapy* / Q000382:microbiology*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D000077731:Meropenem; D009190:Myelodysplastic Syndromes / Q000276:immunology / Q000628:therapy; D012008:Recurrence; D018570:Risk Assessment; D015575:Roxithromycin / Q000008:administration & dosage; D012720:Severity of Illness Index; D013845:Thienamycins / Q000008:administration & dosage; D016896:Treatment Outcome
D013845:Thienamycins; D015575:Roxithromycin; D000077731:Meropenem